Literature DB >> 34363755

Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death.

Justin Taft1, Michael Markson1, Diana Legarda2, Roosheel Patel1, Mark Chan3, Louise Malle1, Ashley Richardson1, Conor Gruber1, Marta Martín-Fernández1, Grazia M S Mancini4, Jan A M van Laar5, Philomine van Pelt6, Sofija Buta1, Beatrijs H A Wokke7, Ira K D Sabli8, Vanessa Sancho-Shimizu8, Pallavi Pimpale Chavan9, Oskar Schnappauf10, Raju Khubchandani11, Müşerref Kasap Cüceoğlu12, Seza Özen12, Daniel L Kastner10, Adrian T Ting3, Ivona Aksentijevich10, Iris H I M Hollink4, Dusan Bogunovic13.   

Abstract

TANK binding kinase 1 (TBK1) regulates IFN-I, NF-κB, and TNF-induced RIPK1-dependent cell death (RCD). In mice, biallelic loss of TBK1 is embryonically lethal. We discovered four humans, ages 32, 26, 7, and 8 from three unrelated consanguineous families with homozygous loss-of-function mutations in TBK1. All four patients suffer from chronic and systemic autoinflammation, but not severe viral infections. We demonstrate that TBK1 loss results in hypomorphic but sufficient IFN-I induction via RIG-I/MDA5, while the system retains near intact IL-6 induction through NF-κB. Autoinflammation is driven by TNF-induced RCD as patient-derived fibroblasts experienced higher rates of necroptosis in vitro, and CC3 was elevated in peripheral blood ex vivo. Treatment with anti-TNF dampened the baseline circulating inflammatory profile and ameliorated the clinical condition in vivo. These findings highlight the plasticity of the IFN-I response and underscore a cardinal role for TBK1 in the regulation of RCD.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IKKE; IRF3; RIPK1; TBK1 deficiency; TNF alpha; autoinflammation; interferon type I; viral susceptibility

Mesh:

Substances:

Year:  2021        PMID: 34363755      PMCID: PMC8380741          DOI: 10.1016/j.cell.2021.07.026

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  77 in total

1.  Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis.

Authors:  Palak Amin; Marcus Florez; Ayaz Najafov; Heling Pan; Jiefei Geng; Dimitry Ofengeim; Slawomir A Dziedzic; Huibing Wang; Vica Jean Barrett; Yasushi Ito; Matthew J LaVoie; Junying Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-11       Impact factor: 11.205

2.  Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.

Authors:  Thijn R Brummelkamp; Sebastian M B Nijman; Annette M G Dirac; René Bernards
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

3.  The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

Authors:  Andrew Kovalenko; Christine Chable-Bessia; Giuseppina Cantarella; Alain Israël; David Wallach; Gilles Courtois
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

4.  RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis.

Authors:  Duan-Wu Zhang; Jing Shao; Juan Lin; Na Zhang; Bao-Ju Lu; Sheng-Cai Lin; Meng-Qiu Dong; Jiahuai Han
Journal:  Science       Date:  2009-06-04       Impact factor: 47.728

5.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

6.  Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo.

Authors:  Apostolos Polykratis; Nicole Hermance; Matija Zelic; Justine Roderick; Chun Kim; Trieu-My Van; Thomas H Lee; Francis K M Chan; Manolis Pasparakis; Michelle A Kelliher
Journal:  J Immunol       Date:  2014-07-11       Impact factor: 5.422

7.  Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.

Authors:  Benjamin R tenOever; Sonia Sharma; Wen Zou; Qiang Sun; Nathalie Grandvaux; Ilkka Julkunen; Hiroaki Hemmi; M Yamamoto; Shizuo Akira; Wen-Chen Yeh; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

8.  Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.

Authors:  Huayi Wang; Liming Sun; Lijing Su; Josep Rizo; Lei Liu; Li-Feng Wang; Fu-Sheng Wang; Xiaodong Wang
Journal:  Mol Cell       Date:  2014-04-03       Impact factor: 17.970

9.  Inflammasome signaling and regulation of interleukin-1 family cytokines.

Authors:  Amy H Chan; Kate Schroder
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

Review 10.  Human TBK1: A Gatekeeper of Neuroinflammation.

Authors:  Liyana Ahmad; Shen-Ying Zhang; Jean-Laurent Casanova; Vanessa Sancho-Shimizu
Journal:  Trends Mol Med       Date:  2016-06       Impact factor: 15.272

View more
  9 in total

1.  Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Charlotte Cunningham-Rundles; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Eric Oksenhendler; Capucine Picard; Anne Puel; Jennifer Puck; Mikko R J Seppänen; Raz Somech; Helen C Su; Kathleen E Sullivan; Troy R Torgerson; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2022-06-24       Impact factor: 8.542

2.  Knowledge Mapping of Necroptosis From 2012 to 2021: A Bibliometric Analysis.

Authors:  Jie Zhang; Luxia Song; Jundi Jia; Wende Tian; Runmin Lai; Zihao Zhang; Jingen Li; Jianqing Ju; Hao Xu
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

3.  Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs.

Authors:  Fengxia Du; Huiwei Sun; Fang Sun; Shiwei Yang; Haidong Tan; Xiaojuan Li; Yantao Chai; Qiyu Jiang; Dongdong Han
Journal:  Front Pharmacol       Date:  2022-06-07       Impact factor: 5.988

4.  CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes.

Authors:  Chao Yang; Mahesh Bachu; Yong Du; Caroline Brauner; Ruoxi Yuan; Marie Dominique Ah Kioon; Giancarlo Chesi; Franck J Barrat; Lionel B Ivashkiv
Journal:  Nat Commun       Date:  2022-06-14       Impact factor: 17.694

5.  Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.

Authors:  Qian Zhang; Daniela Matuozzo; Jérémie Le Pen; Qiang Pan-Hammarström; Bertrand Boisson; Paul Bastard; Helen C Su; Stéphanie Boisson-Dupuis; Laurent Abel; Charles M Rice; Shen-Ying Zhang; Aurélie Cobat; Jean-Laurent Casanova; Danyel Lee; Leen Moens; Takaki Asano; Jonathan Bohlen; Zhiyong Liu; Marcela Moncada-Velez; Yasemin Kendir-Demirkol; Huie Jing; Lucy Bizien; Astrid Marchal; Hassan Abolhassani; Selket Delafontaine; Giorgia Bucciol; Gulsum Ical Bayhan; Sevgi Keles; Ayca Kiykim; Selda Hancerli; Filomeen Haerynck; Benoit Florkin; Nevin Hatipoglu; Tayfun Ozcelik; Guillaume Morelle; Mayana Zatz; Lisa F P Ng; David Chien Lye; Barnaby Edward Young; Yee-Sin Leo; Clifton L Dalgard; Richard P Lifton; Laurent Renia; Isabelle Meyts; Emmanuelle Jouanguy; Lennart Hammarström
Journal:  J Exp Med       Date:  2022-06-16       Impact factor: 17.579

Review 6.  The role of TBK1 in cancer pathogenesis and anticancer immunity.

Authors:  Austin P Runde; Ryan Mack; Peter Breslin S J; Jiwang Zhang
Journal:  J Exp Clin Cancer Res       Date:  2022-04-09

Review 7.  Disorders of ubiquitylation: unchained inflammation.

Authors:  David B Beck; Achim Werner; Daniel L Kastner; Ivona Aksentijevich
Journal:  Nat Rev Rheumatol       Date:  2022-05-06       Impact factor: 32.286

Review 8.  Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19.

Authors:  Caspar I van der Made; Mihai G Netea; Frank L van der Veerdonk; Alexander Hoischen
Journal:  Genome Med       Date:  2022-08-19       Impact factor: 15.266

9.  Development and validation of a novel necroptosis-related score to improve the outcomes of clear cell renal cell carcinoma.

Authors:  Ji Chen; Qiqi Tao; Zhichao Lang; Yan Jin; Guanqi Chen; Xinling Li; Zhixian Yu; Yeping Li
Journal:  Front Genet       Date:  2022-09-12       Impact factor: 4.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.